Safety of tropicamide and phenylephrine in pupillary mydriasis for cataract surgery.

Autor:	K Lodhi SA; Department of Ophthalmology, Malla Reddy Medical College for Women, Hyderabad, Telangana, India., Ramsali MV; Department of Anaesthesiology, Malla Reddy Medical College for Women, Hyderabad, Telangana, India., Kulkarni DK; Department of Anaesthesiology, Malla Reddy Medical College for Women, Hyderabad, Telangana, India., Surender P; Department of Anaesthesiology, Malla Reddy Medical College for Women, Hyderabad, Telangana, India., Murty S; Department of Ophthalmology, Malla Reddy Medical College for Women, Hyderabad, Telangana, India.
Jazyk:	angličtina
Zdroj:	Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society [Saudi J Ophthalmol] 2022 Feb 18; Vol. 35 (2), pp. 108-111. Date of Electronic Publication: 2022 Feb 18 (Print Publication: 2021).
DOI:	10.4103/1319-4534.337859
Abstrakt:	Purpose: A prospective study to evaluate the adverse cardiovascular effects of topical phenylephrine and tropicamide used for pupillary mydriasis before cataract surgery. Methods: A total of 517 consecutive eyes in 517 patients subjected to routine 0.8% tropicamide and 5% phenylephrine eye drops before undergoing cataract surgery (phacoemulsification and manual small-incision surgery) under local or topical anesthesia in a medical college hospital were analyzed. Results: No untoward cardiovascular effects were seen. The increase in blood pressure after 0.8% tropicamide and 5% phenylephrine eye drops was statistically significant, but it was not relevant as it was within clinically permissible limits. Conclusion: The combination of 0.8% tropicamide and 5% phenylephrine eye drops is a safe and effective option for pupillary mydriasis before cataract surgery. Competing Interests: There are no conflicts of interest. (Copyright: © 2022 Saudi Journal of Ophthalmology.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu